Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4858915
Max Phase: Preclinical
Molecular Formula: C49H76N18O11
Molecular Weight: 1093.26
Molecule Type: Unknown
Associated Items:
ID: ALA4858915
Max Phase: Preclinical
Molecular Formula: C49H76N18O11
Molecular Weight: 1093.26
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C49H76N18O11/c1-26(2)22-36(45(77)64-32(7-4-20-58-48(53)54)42(74)66-35(40(50)72)23-27-9-13-29(68)14-10-27)67-43(75)33(8-5-21-59-49(55)56)63-44(76)34-17-18-38(70)61-31(6-3-19-57-47(51)52)41(73)60-25-39(71)62-37(46(78)65-34)24-28-11-15-30(69)16-12-28/h9-16,26,31-37,68-69H,3-8,17-25H2,1-2H3,(H2,50,72)(H,60,73)(H,61,70)(H,62,71)(H,63,76)(H,64,77)(H,65,78)(H,66,74)(H,67,75)(H4,51,52,57)(H4,53,54,58)(H4,55,56,59)/t31-,32-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: RFHHXSZNNSMYFH-PEAOEFARSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1093.26 | Molecular Weight (Monoisotopic): 1092.5941 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):